Talis Biomedical Corp Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Offer Letter, dated July 27, 2023, by and between the Company and Andrew Lukowiak (Filed With SEC on August 2, 2023)
- Offer Letter, dated December 8, 2021, by and between the Company and Robert Kelley (Filed With SEC on December 9, 2021)
- Talis Biomedical Corporation 2021 Inducement Plan (Filed With SEC on November 15, 2021)
- Offer Letter, dated November 1, 2021, by and between the Company and Brian Blaser (Filed With SEC on November 15, 2021)
- Description of Securities (Filed With SEC on March 30, 2021)
- Contract, dated July 30, 2020, by and between the Registrant and the National Institutes of Health (Filed With SEC on January 22, 2021)
- Offer Letter, dated April 23, 2019, by and between the Registrant and Ramesh Ramakrishnan (Filed With SEC on January 22, 2021)
- Offer Letter, dated September 21, 2020, by and between the Registrant and Douglas Liu (Filed With SEC on January 22, 2021)
- Offer Letter, dated August 19, 2020, by and between the Registrant and Robert Kelley (Filed With SEC on January 22, 2021)
- Offer Letter, dated December 1, 2014, by and between the Registrant and Karen E. Flick (Filed With SEC on January 22, 2021)
- Offer Letter, dated April 3, 2020, by and between the Registrant and J. Roger Moody, Jr (Filed With SEC on January 22, 2021)
- Form of Indemnity Agreement, by and between the Registrant and its directors and officers (Filed With SEC on January 22, 2021)
- Nominating Agreement, dated November 1, 2019, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on January 22, 2021)
